How much dividend does Cyclopharm pay?
Over the past 12 months, Cyclopharm paid a dividend of 0.01 AUD . This corresponds to a dividend yield of about 1.15 %. For the coming 12 months, Cyclopharm is expected to pay a dividend of -0.03 AUD.
Cyclopharm Dividend 2025
Cyclopharm Dividend
0 AUD
Cyclopharm Dividend yield
1.15 %
Ticker
CYC.AX
ISIN
AU000000CYC5
How much dividend does Cyclopharm 2025 pay?
According to the latest status from October 2025, Cyclopharm paid a total of 0 AUD per share in dividends within the last 12 months. With the current Cyclopharm price of 0.87 AUD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.
| 1.15 % Dividend Yield | = |
|
Historical Cyclopharm Dividends
A dividend is paid times per year. Last year, the payout months were and .
| Paydate | Dividend |
|---|---|
| 10/1/2023 | 0.01 |
| 4/27/2023 | 0.01 |
| 10/2/2022 | 0.01 |
| 5/4/2022 | 0.01 |
| 10/3/2021 | 0.01 |
| 5/1/2021 | 0.01 |
| 10/4/2020 | 0.01 |
| 4/30/2020 | 0.01 |
| 10/6/2019 | 0.01 |
| 5/5/2019 | 0.01 |
| 10/7/2018 | 0.01 |
| 5/6/2018 | 0.01 |
| 10/1/2017 | 0.01 |
| 5/1/2017 | 0.01 |
| 10/2/2016 | 0.01 |
| 5/11/2016 | 0.01 |
| 11/2/2015 | 0.01 |
1
Cyclopharm dividend history and estimates
In 2024, Cyclopharm paid a dividend amounting to 0 undefined. Dividend means that Cyclopharm distributes a portion of its profits to its owners.
Max
Loading chart...
Dividend
Dividend (Estimate)
Details
Details
Dividend
ⓘDividend Overview
The dividend per year chart for Cyclopharm provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.
Interpretation and Use
A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Cyclopharm’s potential for long-term investment and income generation through dividends.
Investment Strategy
Incorporate the dividend data in evaluating Cyclopharm's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.
Cyclopharm Dividend History
| Date | Cyclopharm Dividend |
|---|---|
| 2027e | 0.03 undefined |
| 2015e | 0.01 undefined |
| 2023 | 0.01 undefined |
| 2022 | 0.01 undefined |
| 2021 | 0.01 undefined |
| 2020 | 0.01 undefined |
| 2019 | 0.01 undefined |
| 2018 | 0.01 undefined |
| 2017 | 0.01 undefined |
| 2016 | 0.01 undefined |
| 2015e | 0.01 undefined |
Is the Cyclopharm Dividend Safe?
Cyclopharm has been increasing the dividend for 1 years.
Over the past 10 years, Cyclopharm has increased it by an annual 0 %.
Analysts expect a Dividend Increase of 0% for the current fiscal year.
Cyclopharm dividend payout ratio
In 2024, Cyclopharm had a payout ratio of 47.65%. The payout ratio indicates the percentage of the company's profits that Cyclopharm distributes as dividends.
3 years
5 years
10 years
25 Years
Max
Loading chart...
Payout ratio
Details
Details
Payout ratio
ⓘWhat is Yearly Payout Ratio?
The yearly payout ratio for Cyclopharm represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.
How to Interpret the Data
A lower payout ratio for Cyclopharm could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.
Using the Data for Investments
Evaluate Cyclopharm's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.
Cyclopharm Payout Ratio History
| Date | Cyclopharm Payout ratio |
|---|---|
| 2027e | 53.44 % |
| 2026e | 51.99 % |
| 2025e | 60.68 % |
| 2024 | 47.65 % |
| 2023 | 47.65 % |
| 2022 | -13.95 % |
| 2021 | -17.79 % |
| 2020 | -12.67 % |
| 2019 | -23.36 % |
| 2018 | -2,000 % |
| 2017 | -44.25 % |
| 2016 | 86.74 % |
| 2015 | 8.55 % |
| 2014 | 47.65 % |
| 2013 | 47.65 % |
| 2012 | 47.65 % |
| 2011 | 47.65 % |
| 2010 | 47.65 % |
| 2009 | 47.65 % |
| 2008 | 47.65 % |
| 2007 | 47.65 % |
| 2006 | 47.65 % |
| 2005 | 47.65 % |
Dividend Details
Understanding Cyclopharm's Dividend Distributions
Cyclopharm’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining Cyclopharm's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
Cyclopharm's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in Cyclopharm’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
Cyclopharm Aktienanalyse
What does Cyclopharm do?
Cyclopharm Ltd is an Australian company that was founded in 1986 and has since been developing innovative medical solutions. The company operates in the field of nuclear medicine and focuses on providing diagnostic and therapeutic products and services. The history of Cyclopharm Ltd began with the development of the Technetium-99m generator, an instrument for generating radioisotopes that can be used in medical imaging. Since then, the company has expanded its offerings and now offers a wide range of products and services. Cyclopharm Ltd's business model is based on research and development of new solutions based on the needs of the medical community and patients. The company works closely with doctors, scientists, and other experts to ensure that its products and services meet the highest standards. Cyclopharm Ltd is divided into various divisions to coordinate and optimize its activities. These include diagnostics, therapy, research and development, as well as sales and marketing. Each division works closely with the others to ensure that the company achieves its goals and provides optimal customer care. Some of Cyclopharm Ltd's most well-known products include the Technetium-99m generator and the radiopharmaceutical Technegas. Technegas is a gas used for lung imaging and plays an important role in diagnosing lung problems. The radiopharmaceutical is produced using the Technetium-99m generator and is an important addition to medical imaging. In addition, Cyclopharm Ltd also develops therapeutic solutions that can be used to treat cancer and other diseases. These include radiopharmaceuticals used in radiation therapy, as well as other solutions tailored to the individual needs of patients. Cyclopharm Ltd is also actively working on improving and expanding its products and services. The company invests in research and development to develop innovative solutions that can improve medical imaging and therapy. Additionally, the company works closely with its customers to better understand their needs and offer them tailored solutions. Overall, Cyclopharm Ltd is an innovative and goal-oriented company that focuses on providing diagnostic and therapeutic solutions in the field of nuclear medicine. The company has a long history of leadership in this field and will continue to be at the forefront of developing solutions that improve the lives of patients and medical professionals. Cyclopharm is one of the most popular companies on Eulerpool.com.Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Frequently Asked Questions about Cyclopharm stock
What is the dividend yield of Cyclopharm?
The current dividend yield of Cyclopharm is 1.15 %.
When does Cyclopharm pay dividends?
Cyclopharm pays a quarterly dividend. This is distributed in the months of May, October, April, October.
How secure is the dividend of Cyclopharm?
Cyclopharm paid dividends every year for the past 1 years.
What is the dividend of Cyclopharm?
For the upcoming 12 months, dividends amounting to -0.03 AUD are expected. This corresponds to a dividend yield of -3.62 %.
In which sector is Cyclopharm located?
Cyclopharm is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cyclopharm kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cyclopharm from 9/11/2023 amounting to 0.005 AUD, you needed to have the stock in your portfolio before the ex-date on 9/1/2023.
When did Cyclopharm pay the last dividend?
The last dividend was paid out on 9/11/2023.
What was the dividend of Cyclopharm in the year 2024?
In the year 2024, Cyclopharm distributed 0.01 AUD as dividends.
In which currency does Cyclopharm pay out the dividend?
The dividends of Cyclopharm are distributed in AUD.
Andere Kennzahlen von Cyclopharm
Our stock analysis for Cyclopharm Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cyclopharm Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
